The future of Trump's drug pricing plan may run through Congress

axios.com/2025/05/27/trump-drug-pricing-congress-most-favored-nation

One of the drug industry's biggest guardrails against President Trump's "most favored nation" drug pricing plan is the fact that it's less enforceable without the involvement of Congress.
Why it matters: Enshrining such a policy in law would be proof of GOP evolution on drug prices — or…

This story appeared on axios.com, 2025-05-27 09:30:00.
The Entire Business World on a Single Page. Free to Use →